Hao Lin
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Bone Metabolism and Diseases
- Extracellular vesicles in disease
- Inflammasome and immune disorders
- Genomics, phytochemicals, and oxidative stress
- Circular RNAs in diseases
Papers in
-
- Extracellular vesicles in disease 6
- Circular RNAs in diseases 4
- Genomics, phytochemicals, and oxidative stress 2
- RNA modifications and cancer 2
-
- MicroRNA in disease regulation 7
- Cancer-related molecular mechanisms research 4
- Co-authors
- Bo Wei (8 shared papers)Jiaqi Chu (4 shared papers)Peng Li (6 shared papers)Jinsong Wei (4 shared papers)Fan Gong (2 shared papers)Jinhui Sun (1 shared paper)Zhuming Chen (1 shared paper)Zhixian Zong (1 shared paper)
- Journals
- International Journal of Nanomedicine (2 papers)International Journal of Medical Sciences (1 paper)Frontiers in Cell and Developmental Biology (1 paper)International Journal of Molecular Sciences (1 paper)Drug Design Development and Therapy (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Hao Lin
25 papers receiving 619 citations
Peers
Comparison fields: 5 of 85
- Cancer Research 128
- Molecular Biology 422
- Biological Psychiatry 14
- Orthopedics and Sports Medicine 42
- Rheumatology 68
Countries citing papers authored by Hao Lin
This map shows the geographic impact of Hao Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao Lin more than expected).
Fields of papers citing papers by Hao Lin
This network shows the impact of papers produced by Hao Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao Lin. The network helps show where Hao Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Hao Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 211 | |
| 2 | 2020 | 63 | |
| 3 | 2014 | 52 | |
| 4 | 2015 | 52 | |
| 5 | 2023 | 49 | |
| 6 | 2013 | 28 | |
| 7 | 2021 | 27 | |
| 8 | 2018 | 20 | |
| 9 | 2018 | 17 | |
| 10 | 2017 | 15 | |
| 11 | 2020 | 12 | |
| 12 | 2019 | 12 | |
| 13 | 2024 | 11 | |
| 14 | 2017 | 10 | |
| 15 | 2022 | 9 | |
| 16 | 2023 | 7 | |
| 17 | 2024 | 6 | |
| 18 | 2022 | 6 | |
| 19 | 2020 | 5 | |
| 20 | 2018 | 3 |
About Hao Lin
Hao Lin is a scholar working on Molecular Biology, Cancer Research, Genetics, Immunology and Pathology and Forensic Medicine, having authored 26 papers that have together received 625 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Extracellular vesicles in disease (6 papers), Mesenchymal stem cell research (4 papers), Cancer-related molecular mechanisms research (4 papers), Circular RNAs in diseases (4 papers), Reproductive System and Pregnancy (2 papers), Genomics, phytochemicals, and oxidative stress (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (128 citations), Molecular Biology (422 citations), Biological Psychiatry (14 citations), Orthopedics and Sports Medicine (42 citations) and Rheumatology (68 citations). Hao Lin has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Bo Wei, Jiaqi Chu, Peng Li, Jinsong Wei, Fan Gong, Jinhui Sun, Zhuming Chen, Zhixian Zong, Huan Zhong and Sien Lin. Their work appears in journals such as International Journal of Nanomedicine, International Journal of Medical Sciences, Frontiers in Cell and Developmental Biology, International Journal of Molecular Sciences and Drug Design Development and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.